Bristol-Myers Squibb

Is the Market Wrong About Bristol-Myers Squibb?
Motley Fool
Fri, 06/16/17 - 09:30 am
Bristol-Myers Squibb
Opdivo
Bristol-Myers Squibb recalls mislabeled Eliquis medications
BioPharma Dive
Thu, 06/15/17 - 05:37 pm
Bristol-Myers Squibb
Eliquis
recalls
labeling
Bristol-Myers Squibb: Still Too Many Uncertainties In The I/O Space
Seeking Alpha
Wed, 06/14/17 - 09:02 pm
Bristol-Myers Squibb
immuno-oncology
Opdivo
How Merck hopes to win in I/O combos: Q&A with Roy Baynes
BioPharma Dive
Wed, 06/14/17 - 11:39 am
Merck
immuno-oncology
Keytruda
Opdivo
Bristol-Myers Squibb
Merck cautiously steps into the PD-(L)1/CTLA-4 checkpoint fray. But should it ‘go big or go home’ instead?
Endpoints
Fri, 06/9/17 - 11:13 am
Merck
anti-PD-L1
Keytruda
MK-1308
Bristol-Myers Squibb
[video]Bristol-Myers Squibb CEO: Critical that treatments reach patients
Yahoo/CNBC
Wed, 06/7/17 - 10:11 am
patients
cancer
Bristol-Myers Squibb
drug pricing
ASCO 2017
Giovanni Caforio
Why Array BioPharma Inc. Sank 13.5% in May
Motley Fool
Wed, 06/7/17 - 10:08 am
Array Biopharma
Bristol-Myers Squibb
Merck
Opdivo
Keytruda
binimetinib
encorafenib
How Did Bristol Lose An Edge In Lung Cancer? It's No Mystery, Says New R&D Boss
Forbes
Sat, 06/3/17 - 09:28 am
Bristol-Myers Squibb
lung cancer
R&D
Opdivo
Merck
Keytruda
The immuno-oncology market prepares for the inevitable question: 'What's next?'
Medical Marketing and Media
Thu, 06/1/17 - 02:51 pm
immuno-oncology
Keytruda
Merck
Opdivo
Bristol-Myers Squibb
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy
Xconomy
Wed, 05/31/17 - 10:59 am
ASCO 2017
cancer
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Prepping for ASCO? Investor Brad Loncar offers his own breakdown of what to watch for
Endpoints
Tue, 05/30/17 - 11:48 am
ASCO
IDO inhibitors
CAR-T
PDL-1 inhibitors
Merck
Incyte
NewLink Genetics
Novartis
Juno Therapeutics
Bristol-Myers Squibb
Johnson & Johnson appeal of $72M talc verdict could hinge on Bristol-Myers Squibb's SCOTUS case
Fierce Pharma
Thu, 05/11/17 - 06:25 pm
JNJ
Bristol-Myers Squibb
Supreme Court
Is Pfizer really weighing a BMS buy? Clues from Q1's earnings call say it just may be
Fierce Pharma
Wed, 05/3/17 - 10:09 am
Pfizer
earnings
M&A
Bristol-Myers Squibb
Despite Worries, Bristol-Myers' Opdivo Keeps Racking Up Sales
Motley Fool
Sat, 04/29/17 - 10:05 am
Bristol-Myers Squibb
Opdivo
earnings
Bristol-Myers wins approval in China for oral treatment for chronic hepatitis C virus
Marketwatch
Fri, 04/28/17 - 10:32 am
Bristol-Myers Squibb
China
hepatitis C
Daklinza
Bristol-Myers tops Street 1Q forecasts
Yahoo/AP
Thu, 04/27/17 - 09:37 am
Bristol-Myers Squibb
earnings
Q1 Earnings Preview: AbbVie, AstraZeneca, BMS, Celgene, Roche, Sanofi
BioPharma Dive
Wed, 04/26/17 - 09:29 pm
earnings
AbbVie
AstraZeneca
Bristol-Myers Squibb
Celgene
Roche
Sanofi
Bristol-Myers Squibb’s 1Q17 Estimates: Expect Growth!
Market Realist
Tue, 04/25/17 - 11:45 pm
Bristol-Myers Squibb
earnings
Biogen Says It's Back and Ready for ‘Highly Active’ Dealmaking
Yahoo/Bloomberg
Sun, 04/23/17 - 09:54 am
Biogen
M&A
Bristol-Myers Squibb
Bristol-Myers NASH drug reduces liver fat in midstage study
Yahoo/Reuters
Sat, 04/22/17 - 01:37 pm
Bristol-Myers Squibb
NASH
BMS-986036

Pages